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Great controversies and misunderstandings have developed around the relatively 
recently coined term disorders of sex development (DSD). In this article, we question 
the wisdom of including XX individuals with congenital adrenal hyperplasia (CAH) in the 
DSD category and develop arguments against it based on the published literature on the 
subject. It is clear that females with CAH assigned the female gender before 24 months 
of age and properly managed retain the female gender identity regardless of the Prader 
grade. Females with CAH and low Prader grades have the potential for a normal sexual 
and reproductive life. Those with greater degrees of prenatal androgen exposure (Prader 
grades IV and V) raised as females also identify themselves as females but experience 
more male-like behavior in childhood, have a greater rate of homosexuality, and have 
greater difficulty with vaginal penetration and maintaining pregnancies. Improvement in 
surgical techniques, better endocrinological, psychological, and surgical follow-up may 
lessen these problems in the future. Given the fact that the term DSD includes many 
conditions with problematic gender identity and conflicts with the gender assigned at 
birth, it may be appropriate to exclude females with CAH from the DSD classification.
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A consensus paper in 2006, which reflected the opinion of a group of international experts in the 
subject, led to the substitution of the term Intersex for disorders of sexual development (DSD). The 
term intersex was considered to be vague and pejorative, and DSD was deemed more appropriate 
(1). It may be pertinent to go back and analyze the terms.
Intersex refers to a condition in which the appearance of the external genitalia falls somewhere 
between the two natural sexes, male and female, required for reproduction. Ambiguity of the external 
genital organs presents many problems for the affected individual, her or his parents, and the medical 
team involved. The problems begin at birth when the baby is usually declared to be a boy or a girl 
and a gender-appropriate name is given and continue for the entire life of the affected individual with 
physical and psychological repercussions.
The term “disorders of sex development” implies that there has been an alteration or deviation (or 
more politically correctly, a difference) in the normal path of development of the sex organs, which 
are better referred to as genitals organs involved in sexual activity and reproduction.
The consensus paper included under the umbrella of DSD, conditions such as vaginal agenesis and 
Klinefelter syndrome (even though the external genitals are normal and pose no doubts regarding 
gender assignment or identity) but does not include undescended testes or hydrocele, conditions that 
clearly involve reproductive organs. Also included as DSD was severe hypospadias (without giving a 
clear definition of what is meant by severe or the underlying cause of the malformation). These and 
other arbitrary choices give the impression that the conditions grouped as DSD were selected with 
questionable scientific criteria.
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Professionals, particularly physicians, embraced this new 
terminology readily and with little questioning, perhaps to appear 
modern, well informed, and sensitive to the current controversies 
in treatment (2, 3). Lay public and advocacy groups also welcomed 
the changes, but some patients and families did not approve of the 
inclusion of congenital adrenal hyperplasia (CAH) as DSD (4).
Controversial issues in DSD relate mostly to cases where there 
is little evidence for what is the best choice for gender assign-
ment and the timing of corrective surgery if indicated. This is 
particularly important when the long-term outcome of a given 
condition is unclear or poor as is the case with many instances 
of gonadal dysgenesis, male aphallia, ovotesticular DSD, XY 
cloacal exstrophy (5), and extreme micropenis among others. 
For those cases, a reconsideration of practices prior to 2006, such 
as the automatic female gender assignment when the phallus 
was considered inadequate (6), was probably beneficial. This 
clinical conduct was based on the theory that the sex of rear-
ing, the appearance of the external genitalia, and the hormonal 
milieu were the critical factors in determining gender identity 
(6). However, the clinical application of this hypothesis was often 
unsuccessful (7) probably because it disregarded the effect of 
prenatal exposure to androgens, which has an unquestionable 
influence in future gender-related behavior (8). Nevertheless, the 
influence of the sex of rearing in future gender identity cannot be 
completely discarded (9).
On the other hand, the inclusion of CAH in XX individuals in 
the DSD group may not be appropriate. CAH is one of the most 
common causes of ambiguous genitals. If one considers that 95% 
of these patients when properly managed from the endocrinologi-
cal and surgical points of view will have a female gender identity 
(10) and potential for sexual activity (11) and normal conception 
rates, if not always fertility (12), it is difficult to comprehend 
how controversies about gender assignment and management 
extended to this condition. A possible explanation is that many 
diseases, with such as genital appearance at birth, were lumped in 
the same category leading sometimes to confusion.
This confusion among the lay public is well represented in the 
2007 Argentine film XXY that won the Critic’s Week award in 
Cannes in 2007. The protagonist is supposed to represent a girl 
with CAH who at puberty rebels against her medical treatment, 
feels uncertain about her gender, and exhibits male sexual behav-
ior. Of course, the karyotype of the title corresponds not to CAH 
but to Klinefelter’s syndrome. The protagonist is supposed to have 
undergone five surgical procedures and yet can have intercourse 
and urinate as a male. If her condition was supposed to be a case 
of Prader V CAH and still had a functioning phallus at puberty, 
the nature of the operations she had is perplexing. Besides, she 
was supposedly taking corticosteroids which she decided to stop, 
a potentially life-threatening decision in a salt loser. In short, the 
film propagates erroneous information about CAH such as is 
often used as an argument against female gender assignment and 
early corrective surgery.
It is well known that girls with salt-wasting CAH tend to 
exhibit more tomboyish behavior (13), and in adulthood may 
have less heterosexual preferences and may be less comfortable 
with their femininity (14). Nevertheless, in the few cases of gen-
der dysphoria in XX CAH patients reported in the literature, it 
is not clear if lack of compliance with steroid replacement played 
a role (10, 15).
One unintended clinical experiment was reported by Woelfle 
et al. (16). In a survey of German endocrinologists, 16 individu-
als with XX karyotype with “complete virilization” (but certainly 
without palpable testes) with an initially missed diagnosis of CAH 
were raised as males. Six of them were reassigned to female in the 
first 19 months of life, and they all maintained female gender role. 
In 10 patients, the correct diagnosis was established after 3 years 
of age. In seven of them, the male gender was maintained with 
apparently only one expressing doubts about gender identity. 
In three cases of late gender, reassignment to female was poorly 
tolerated in one of them.
Of course, with good neonatal care, Woelfle et al.’s series should 
have only historical interest since all apparently male newborns 
with bilateral non-palpable testes should be emergently evaluated 
for possible CAH with karyotype and hormonal studies.
Thus, it appears that assigning the male gender to Prader 
V  CAH individuals with an XX karyotype diagnosed in the 
first 2 years of life is not appropriate since they will be certainly 
infertile, have short stature, and seem to have a greater incidence 
of gender dysphoria than when assigned the female gender and 
correctly treated with steroid replacement. Also, it is not clear 
if the increased incidence of cardiac disease induced by early 
androgen exposure can be prevented with “good hormonal 
management” (17).
Some authors argued that given the “unsatisfactory” results 
(18, 19) of some operations for genital ambiguity, there should 
be a moratorium on all gender (genital?) surgery in infants 
(20). The authors argue that there are US and international legal 
precedents for such action. Mistakenly, they appear to confuse 
truly “unnecessary operations” or “not medically indicated” such 
as male or female circumcision (for which the ban makes sense) 
with procedures done to correct an anatomical defect such as 
hypospadias repair or correction of CAH, which have the similar 
medical, ethical, and philosophical foundations as correction of 
a cleft lip or some forms of craniosynostosis, procedures about 
which little controversy exists.
In addition, those proposing not to operate or make a female 
gender assignment in Prader V CAH fail to provide evidence of 
the medical and psychological outcomes of children brought up 
without a clear gender assignment who grow up with ambiguous 
genitals. Introducing such management strategy would represent 
the type of human experimentation that requires serious medical, 
ethical, and philosophical consideration.
Why should female gender assignment and early surgical 
correction in females with CAH be questioned and not male 
gender assignment and early correction in males with primary 
hypospadias? Consider the similarities of the two diseases: in 
both, the chromosomal sex is unequivocal, both can be success-
fully corrected with surgery leading to potentially normal sexual 
and reproductive functions, and in both gender, dysphoria is rare 
(10, 15, 21). Furthermore, reconstructive procedures for both 
conditions have less than perfect results. The complication rate 
and need for re-operations for fistulas persistent curvature and 
imperfect cosmetic appearance in cases of proximal hypospadias 
(22, 23) are comparable to the need for reoperation at puberty for 
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introital stenosis with old operations in CAH (24). We know that 
repair of hypospadias in older children carries a higher complica-
tion rate that when done in infancy (25–28). The consequences 
of growing up with ambiguous genitals (i.e., a girl with massive 
clitoromegaly) are unknown, and evidence that postponing geni-
tal surgery until the age of consent will yield better results has not 
been published (29, 30).
It is worth analyzing some of the reports suggesting poor 
results of early reconstructive surgery in CAH. For example, 
Creighton et al. (19) reported unsatisfactory cosmetic results in 
41% of patients operated in infancy and that almost all required 
further surgery either to improve cosmesis or to achieve an 
adequate introital caliber. These unsatisfactory results may relate 
to techniques used in London in the 1980s and 1990s. More 
recently, Lesma et  al. (11) reported on long-term follow-up of 
sexually active women with CAH operated in childhood with the 
Passerini technique (31). Although there was decreased clitoral 
sensitivity, all had satisfactory intercourse and orgasm with no 
differences with normal controls.
Gastaud et al. (32) reported that 18 of 22 women in their report 
experienced pain during vaginal penetration. The proportion of 
women with low Prader grades who had vaginal intercourse was 
similar to the controls (more than 90%) as opposed to high Prader 
grades (37%). It should be noted that this report includes patients 
who had clitorectomies and “vaginal pull-through” operations, 
which have long been abandoned.
Bailez et al. (18, 31) reported in 1992 that 78% of women oper-
ated in childhood (also with techniques no longer used) required 
further surgery for introital stenosis. The procedure required was 
considered minor, and the success rate was high.
From the above, it can be concluded that CAH females with 
low Prader grades often achieve normal heterosexual sexual 
activity and pregnancies. In contrast, Prader grades IV and V 
although persevering female gender identity tend to have less 
heterosexual relationships, and those who chose to have them 
experience greater difficulty with vaginal penetration and 
maintaining pregnancies. Greater prenatal androgen exposure, 
poor compliance with hormonal replacement, and inadequate 
surgical techniques may contribute to these differences. Future 
efforts should be directed at achieving better anatomical results 
with the operations performed, better counseling regarding the 
importance of life long hormonal replacement, and close follow-
up till sexual maturation is achieved and thereafter.
It is to be expected that the long-term results and type of 
follow-up evaluation currently used will yield better long-term 
results (33–35).
The term DSD carries implications of high rates of dissatisfac-
tion with gender assignment and with surgeries performed to 
match such gender assignment. This is not the case with well-
managed cases of CAH. In fact, in a recent article by a member of 
the consensus group (1), it is stated that “Most children with 46,XX 
karyotype and DSD have congenital adrenal hyperplasia due to 
21-hydroxylase deficiency and should be regarded as unchallenged 
females” (36). For these reasons, we propose that CAH should not 
be included in the category of DSD.
One of the risks of misunderstandings in this topic is that the 
information available to the public is not always objective and 
unbiased, and often interferes with the relationship between the 
medical professionals and the families of affected children, and 
it may also influence politicians and lawmakers to introduce 
restrictive legislation that will ultimately hurt, rather than help, 
patients.
In fact, it might be better to stop the use of the term DSD 
altogether and instead use the specific diagnosis for every given 
condition.
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